Technical variations in prostatic immunohistochemistry: Need for standardisation and stringent quality assurance in PSA and PSAP immunostaining

Journal of Clinical Pathology

Volumn 57, Issue 7, 2004, Pages 687-690

  Varma, M ^a   Berney, D M ^b   Jasani, B ^a   Rhodes, A ^c  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DILUTION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY CONTROL; QUESTIONNAIRE; REGISTER; STANDARDIZATION; TECHNIQUE; TISSUE; UNITED KINGDOM;

ACID PHOSPHATASE; EUROPE; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY CONTROL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 3142585287     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.014894     Document Type: Article

References (10)

1. Wick MR, Mills SE. Consensual interpretive guidelines for diagnostic immunohistochemistry. Am J Surg Pathol 2001;25:1208-10.
2. Seidel T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol 2001;25:1204-7.
3. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol 2001;25:794-801.
4. Varma M, Morgan M, Jasani MB, et al. Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: implications for diagnostic prostatic pathology. Am J Clin Pathol 2002;118:202-7.
5. Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 2002;117:471-7.
6. Mhawech P, Uchida T, Pelte M. Immunohistochemical profile of high-grade urothelial carcinoma and prostate adenocarcinoma. Hum Pathol 2002;33:1136-40.
7. Epstein JI. PSA and PAP as immunohistochemical markers in prostate cancer. Urol Clin North Am 1993;20:757-69.
8. Bostwick DG. Neoplasms of the prostate. In: Bostwick DG, Eble JN, eds. Urologic surgical pathology, 1st ed. St Louis USA: Mosby, 1997:344-421.
9. von Wasielewski R, Mengel M, Wiese B, et al. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002;118:675-82.
10. Riera J, Simpson JF, Tamayo R, et al. Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer. The Quickgel method. Am J Clin Pathol 1999;111:329-35.